je.st
news
Home
› Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
Frost & Sullivan Recognizes KAER's Game-Changing Innovating Aerosol Drug Delivery Methods For High-Dose Respiratory Disease Therapeutics
2013-02-27 02:15:32| drugdiscoveryonline Home Page
Based on its recent analysis of the aerosol drug delivery technology market, Frost & Sullivan recognizes KAER Biotherapeutics with the 2012 North America Frost & Sullivan Award for Technology Innovation for SUPRAER
Tags: methods
delivery
drug
disease
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||